Filed before 2025Filed 31 October 2016
Alcresta Therapeutics, Inc. has sold $50.9M so far
Alcresta Therapeutics, Inc., a biotech company based in Newton, MA, has sold $50.9M so far in its equity round, according to a filing dated 31 October 2016.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 31 October 2016
- First filed
- 14 June 2016
- Round
- Equity round (amended filing)
- Amount sold
- $50.9M
- Offering size
- $50.9M
- Investors so far
- 13
- Based in
- Newton, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 97% of the 1,506 tracked raises with an amount filed in 2016, and than 93% of the 120 in biotech.
Alcresta Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 3 Mar 2020 | New filing | $10M | Another raise |
| 23 Jan 2019 | New filing | $5M | Another raise |
| 25 Sep 2017 | New filing | $10M | Another raise |
| 31 Oct 2016 | Amended filing | $50.9M | This raise |
| 14 Jun 2016 | New filing | $49.4M | This raise |
More with Frazier Life Sciences on the board
- Enlaza Therapeutics, Inc.$15M
- Sudo Biosciences, Inc.$63.6M
- MBX Biosciences, Inc.$46.7M
- 98point6 Inc.$20.9M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.